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The Duchenne and Becker muscular dystrophies are caused by mutation of dystrophin gene and primarily affect skeletal and
cardiac muscles. Cardiac involvement in dystrophic GRMD dogs has been demonstrated by electrocardiographic studies with the
onset of a progressive cardiomyopathy similar to the cardiac disease in DMD patients. In this respect, GRMD is a useful model
to explore cardiac and skeletal muscle pathogenesis and for developing new therapeutic protocols. Here we describe a protocol
to convert GRMD canine fibroblasts isolated from heart and skin into induced cardiac-like myocytes (ciCLMs). We used a mix
of transcription factors (GATA4, HAND2, TBX5, and MEF2C), known to be able to differentiate mouse and human somatic cells
into ciCLMs. Exogenous gene expression was obtained using four lentiviral vectors carrying transcription factor genes and different
resistance genes. Our data demonstrate a direct switch fromfibroblast into ciCLMswith no activation of early cardiac genes. ciCLMs
were unable to contract spontaneously, suggesting, differently frommouse and human cells, an incomplete differentiation process.
However, when transplanted in neonatal hearts of SCID/Beige mice, ciCLMs participate in cardiac myogenesis.
1. Introduction
Ischemic heart disease is one of the leading causes of death
worldwide and so far therapeutic approaches are limited [1].
Because of the negligible regenerative ability, the heart has
been considered for nearly a century as a terminal differenti-
ated postmitotic organ [2]. Although this concept is currently
outdated, the heart is not able to heal itself after injury
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by any native processes, and fibrotic scars replace necrotic
tissue. This stiffens the heart tissue and prevents the normal
contractility of cardiomyocytes. Cardiac fibroblasts (CFs) are
widely involved in the heart healing process and represent
one of the largest cell populations in the myocardium [3]. For
this reason, CFs have been identified as ideal cell source for
in vivo direct conversion approaches [4].
The discovery ofMyoD, asmaster gene for skeletalmuscle
differentiation [5], generated a broad interest in cell repro-
gramming by using defined factors.Unfortunately, for cardiac
differentiation, a single master gene such as MyoD is not
known yet. Ieda et al. reported that the forced expression of
three exogenous transcription factors (Gata4, Mef2c, and
Tbx5) in neonatal cardiac and dermal fibroblasts is sufficient
for the conversion to cardiomyocyte-like cells in vitro [6].
After this first elegant study, several groups reported similar
results using different transcription factors and microRNA
[7–10]. Recently, two groups reported the conversion of
fibrotic scar tissue into induced cardiomyocytes-like cells
in vivo through retroviral delivery of GATA4, MEF2C, and
TBX5 (GMT) transcription factors [11, 12]. In the same year,
Olson’s group demonstrated an improvement of the cardiac
differentiation rate combining the GMT with Hand2 both in
vitro and in vivo [10]. Similar results have been achieved lately
on human fibroblasts using the same protocol [13, 14].
These discoveries hold a great promise for the treatment
of heart chronic diseases where the invading fibrotic tissue
could be replaced by contractile cardiomyocytes. Muscular
dystrophies (MDs) are a group of inherited diseases caused
by mutations in the Dystrophin Glycoprotein Complex.
Patients affected byMDs, in particular Duchenne and Becker
muscular dystrophy, who survived to the third decade of
life are affected by cardiomyopathy and heart failure is
the main cause of death for these patients [15–17]. The
heart degeneration and remodelling lead to the formation of
subepicardial fibrosis of the inferolateral wall [18] that could
represent the ideal target for direct lineage reprogramming
to cardiomyocyte lineage. Among the widely used animal
models of DMD, the golden retriever muscular dystrophy
(GRMD) dog is considered the closest model to the human
disease in terms of size and pathological onset of the disease.
In fact, the clinical course of GRMD dogs is characterized
by progressive muscle wasting, degeneration, fibrosis, and
shortened lifespan [19–21]. Cardiac involvement in GRMD
dogs has been demonstrated by electrocardiographic studies,
revealing a progressive cardiomyopathy similar to DMD
patients [22–24]. In this respect, GRMDdog is a usefulmodel
for the development of new therapeutic protocols to improve
cardiac function [25].
In this study we aim to evaluate the direct lineage conver-
sion strategy (GATA4, MEF2C, TBX5, and HAND2) on car-
diac and skin fibroblasts isolated from a large animal model
of Duchenne muscular dystrophy (GRMD). Canine-induced
cardiac-like myocytes (ciCLMs) expressed late cardiac mark-
ers genes, immature sarcomeric structures, and engrafting
ability in vivo.
2. Material and Methods
2.1. Isolation and Culture of Skin Canine Fibroblasts. Canine
skin samples from GRMD dogs were obtained from fresh
abdominal skin biopsies and isolated as previously shown
[26]. Obtained canine fibroblasts were kept in culture in
DMEM supplemented with 15% FBS and antibiotics. The
mediumwas replaced every two days. Cells were frozen, after
being cultured for one week, and then plated for lentiviral
transduction.
2.2. Isolation and Culture of Cardiac Canine Fibroblasts. Left
ventricular heart biopsy from a deceased GRMD dog was
chopped into small pieces and plated on a tissue culture dish
in DMEM : 199 (4 : 1), 15% FBS and antibiotics. Cardiac fibro-
blasts spread out from the minced heart after few days and
one week later cells were frozen. The medium was replaced
every two days.
2.3. Cell Culture. Bj-1 and canine cardiac and skin fibroblast
were maintained in DMEM supplemented with 5mM L-
glutamine, 5mM sodium pyruvate, 100 IU/mL penicillin,
100 𝜇g/mL streptomycin (all from Invitrogen), and 20% fetal
bovine serum (Gibco). Neonatal rat cardiomyocytes were
used for the preparation of the induction medium (IM) and
for coculture with transduced fibroblasts. Neonatal rat car-
diomyocytes were isolated using the Neonatal Cardiomy-
ocyte isolation kit from Worthington Biochemical Corpora-
tion (Lakewood, NJ, USA) and cultured in DMEM 10% FBS
(Invitrogen, Carlsbad, CA, USA). Medium was replaced and
frozen every day and subsequently used in the preparation
of the induction medium (IM). Primary cell cultures were
maintained in a humidified incubator at 37∘C with 5% CO
2
.
2.4. Plasmid Cloning and Expansion. Lentiviral vectors were
prepared by using standard procedures. Bacterial stocks were
grown in Luria-Broth medium ON at 37 degrees. All vectors
preparations were obtained using a GenElute HP Endotoxin-
Free Plasmid Maxiprep Kit (Sigma) and Plasmid DNA was
quantified using Nanodrop system.
The plasmid carrying the human transcription factors
(GATA4, MEF2C, TBX5, and HAND2) and 𝛼-MyHC-GFP
cardiac differentiation reporter gene were subcloned into
the lentiviral vector pCHMWS carrying different resistance
genes (Figure 2(a)).
2.5. Lentivirus Production. HEK 293 cells were seeded at
density of 6 × 106 in a 10 cm tissue culture dish and at the day
after being transfected, using Lipofectamine 2000 (Invitro-
gen), with ninemicrograms of the individual transfer vectors.
Cells were kept in OptiMem; after six hours the medium
was replaced to 10mL of fresh DMEM with 10% FBS and
antibiotics. The medium containing lentiviral particles was
harvested after 36 hours of transfection, filtered with 0,45𝜇m
cellulose filter.
2.6. Viral Transduction andDifferentiation. Skin, cardiac, and
Bj-1 fibroblasts were plated at density of 1 × 105/cm2 on Nunc
Stem Cells International 3
culture dishes (ThermoFisher Scientific) and transducedwith
fresh lentiviral supernatant (MOI= 50)mixedwith polybrene
at final concentration of 4𝜇g/𝜇L (Sigma).The day after trans-
duction with the mix of transcription factors, medium was
replaced with induction medium (IM), containing 10% con-
ditionedmedium (obtained from neonatal rat cardiomyocyte
culture), DMEM/199 (4 : 1), 10% FBS, 5% horse serum (HS),
antibiotics, nonessential amino acids, essential amino acids,
B-27, insulin-sodium selenite-transferrin, vitamin mixture,
and sodium pyruvate (Invitrogen) [10]. Eukaryotic selection
antibiotics (Blasticidin 5𝜇g/mL,Hygromycin 100𝜇g/mL, and
Zeocin 200𝜇g/mL) were added to the IM the second day
after transduction and kept in culture for oneweek. Induction
medium was replaced every two days.
2.7. Real Time PCR. Total RNAwas extracted from cells using
RNeasy Mini Kit (Qiagen) and 1 𝜇g was reverse transcribed
to cDNA by Superscript III Reverse Transcriptase (Life Tech-
nologies). Real Time PCR was performed using Platinum
SYBR Green qPCR SuperMix-UDG and Mastercycler ep
realplex (Eppendorf). qPCR experiments were performed
using the following primers:
hGATA4: Fw5󸀠-tctcagaaggcagagagtgtg; Rv5󸀠-ggttga-
tgccgttcatcttgt;
hMEF2C: Fw5󸀠-aagaagggccttaatggctgt; Rv5󸀠-atctcg-
aagttgggaggtgga;
hTBX5: Fw5󸀠-gcatggagggaatcaaagtg; Rv5󸀠-cttcgtttt-
gggattaaggcc;
hHAND2: Fw5󸀠-atgagtctggtaggtggttttcc; Rv5󸀠-catact-
cggggctgtaggaca;
dGATA4: Fw5󸀠-cgggctatcatcccactatg; Rv5󸀠-gcgact-
ggctgacagaagat;
dMEF2c: Fw5󸀠-cccgatgcagacgattca; Rv5󸀠-caaaattgg-
gaggtggaaca;
dTBX5: Fw5󸀠-ccttctaccgctcaggctac; Rv5󸀠-caggctggg-
cacaggctca;
dHAND2: Fw5󸀠-ccgctaaccgcaaggaga; Rv5󸀠-cgtcttgat-
cttggagagtttg;
ACTC1: Fw5󸀠-tcccatcgagcatggtatcat; Rv5󸀠-ggtacggcc-
agaagcataca;
CNX43: Fw5󸀠-ccagttgagattccactcagt; Rv5󸀠-gttgagtac-
cacctccactga;
TNNT2: Fw5󸀠-atgtctgacgtagaagaggag; Rv5󸀠-atcacc-
ttccgcgttggtctc;
MYH6: Fw5󸀠-gccctttgacattcgcactg; Rv5󸀠-ggtttcagcaat-
gaccttgc.
2.8.Western Blotting. Cells were collected 14 days after trans-
duction and resuspended in Ripa buffer (Sigma) supple-
mented with 10mm NaF (Sigma), 0.5mm NaOrthovanadate
(Sigma), 1 : 100 Protease Inhibitor Cocktail (Sigma), and 1mm
PMSF (Sigma).Western blot analysis was performed on 40𝜇g
of cell lysate, using anticardiac-TnnI (Tnni3; Abcam; ab19615)
1 : 100 as primary antibody and secondary HRP-conjugated
antibodies (Santa Cruz), 1 : 500. Bands were detected and
pictured at Bio-Rad GelDoc by means of Pico substrate
(Thermo Fisher Scientific; Dura substrate for DYS analysis);
densitometry analyses were carried on gels loaded, blotted,
and detected in parallel by means of QuantityOne software
(Bio-Rad).
2.9. Immunocytochemistry and Flow Cytometry Analyses.
Cells were fixed 14 days after transduction in 2% PFA,
permeabilized with 0.2% Triton, and blocked with donkey
serum (Sigma). Cells were then stained overnight at 4∘Cwith
different primary antibodies. Antibody dilutions were the
following: anti-Vimentin (Sigma; V6630) 1 : 200, anti-Ki67
(sigma; ab15580) 1 : 200; anti-GFP (Abcam; ab545) 1 : 500;
anti-sarcomeric𝛼-actinin (𝛼SA; Abcam; ab9465) 1 : 200; anti-
connexin 43 (Santa Cruz; sc-9059) 1 : 300; MyHC (MF20;
Hybridoma) 1 : 3; cardiac troponinT (Abcam; ab10214) 1 : 200.
Secondary fluorescents antibodies (Alexa-Fluor; 1 : 500)
were used for detection. Nuclei were stained with Hoechst
33342 (Sigma).
Flow cytometry analyses were performed according to
standard procedures with the following antibodies: anti-
CD90/Thy1 antibody (FITC) (Abcam; ab124527); anti-cardiac
troponin T (Abcam; ab10214).
Cardiac troponin T expression was analyzed by intra-
cellular staining; cells were fixed with 2% PFA, blocked
with donkey serum (Sigma), and permeabilized by fixation/
permeabilization (BD Cytofix/Cytoperm).
2.10. In Vivo Xenotransplant Experiment. GHMT GFP posi-
tive cells were sorted 7 days after transduction using AriaIII
FACS and 5 × 104 were injected directly in the heart of 2-day-
old SCID/Beige-mice pups. After 2 weeks, mice were sacri-
ficed and the whole heart was embedded in OCT (Sakura,
Tissue-Tek) and cut as 10𝜇msections using a cryostat (Leica).
Sections were fixed in 4% PFA, permeabilized by solution
PBS-BSA1%-Triton X-100, and immunostained by antibod-
ies against dystrophin (NCL-DYS2-NCL-DYS3; Novocastra;
1 : 50), myosin heavy chain (MF20; Hybridoma; 1 : 3), and
GFP (Abcam; ab5450).
2.11. Statistical Analysis. Values are expressed as mean ± SD,
and when two groups were compared, unpaired Student’s 𝑡-
test was used. When more than two groups were compared,
a two-way analysis of variance (ANOVA) was used and a
probability of less than 5% (𝑝 < 0.05) was considered to be
statistically significant (Bonferroni post hoc test). Statistical
significance of the differences between the percentage values
was assessed by the Kruskal-Wallis one-way ANOVA on
ranks, with a Bonferroni-Dunn post hoc test, and significance
was scored when 𝑝 < 0.05 for both tests.
3. Results
3.1. Characterization of Fibroblast Populations. In the last
years, several groups reported the possibility to induce direct
reprogramming from adult somatic cells to other lineages
through the overexpression of a set of transcription factors
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or miRNA [6, 10, 27–31]. In this study we tested whether
the same four cardiac transcription factors, GHMT, shown
previously to direct the reprogramming on neonatal human
foreskin fibroblasts [14], were able to reprogram fibroblasts
isolated from GRMD dogs. According to those previous
studies, canine fibroblasts were considered for the repro-
gramming protocol due to their easy access and ability to pro-
liferate in vitro. We characterized canine fibroblasts for their
morphology (Figures 1(a)–1(c)), expression of Vimentin
as mesodermal marker, and Ki67 as proliferative marker
(Figures 1(d)–1(f)) and cell growths have been analysed
(Figure 1(g)). In addition, Bj-1 human fibroblasts, a commer-
cially available adult human dermal fibroblast cell line, were
used as control. The three fibroblast populations resulted
100% positive for Vimentin and fibroblasts derived from
skin and cardiac biopsies were, respectively, 79% and 65%
positive for Ki67, slightly lower than Bj-1 (87%). In order to
avoid possible contamination of progenitor cells, known to
be more susceptible to reprogramming, we employed cell-
sorting strategy in our freshly isolated primary cultures to
isolate homogenous fibroblast populations. FACS analysis
showed that cells were homogenously positive for CD90
(Thy1) (Figure 1(i)), similarly to Bj-1 cell line. CD90 positive
cells were subjected to the reprogramming protocol.
3.2. Transcription Factors Overexpression. To determine the
best set of transcription factors able to convert fibroblast
to cardiac-like cells, we generated lentiviruses carrying dif-
ferent genes involved in cardiac differentiation including
GATA4, HAND2, MEF2C, TBX5, MESP1, and BAF60c. A
cardiac muscle specific promoter (alpha myosin heavy chain,
𝛼MyHC) was used to drive expression of GFP in our cell
system, as gene tracer for cardiac differentiation. We infected
Bj-1 cells with different mix of lentiviral vectors and we
evaluated the conversion potential by GFP expression. In our
hand, the best set of genes resulted in being GHMT (data
not shown). Indeed, the overexpression of GHMT has been
shown to be sufficient for the reprogramming of tail tip and
cardiac fibroblast [10] and human fibroblasts [14] to cardiac-
like cells. In the following experiments, coding sequence
genes for GATA4, HAND2, MEF2C, and TBX5 (GHMT)
were cloned into lentiviral vectors carrying different gene
resistance (Figure 2(a)) and used to infect CD90+ fibroblasts
from skin (SF) and cardiac (CF) GRMD biopsies and Bj-
1 human cell line. Cells were infected with a MOI of 50
and after 2 days few GFP positive cells were detected in all
samples (Figure 2(b)). Then the medium was replaced with
the differentiation medium and cells were maintained in
culture up to 28 days.GFPpositive cells underwent drastically
morphological changes, resulting in flattened and binucleated
cells similar to foetal cardiomyocytes (Figure 2(c)). GFP
positive GHMT CFs were sorted and counterstained, alone
(Figure 2(d), upper left panel) or in coculture with rat car-
diomyocytes (Figure 2(d), lower left panel), for myosin heavy
chain in order to confirm the specificity of our differentiation
protocol. GFP and myosin heavy chain (MyHC) colocalized
in the majority of the cells (Figure 2(d), left upper panel).
However, we could also find occasionally GFP positive cells
negative for MyHC (Figure 2(d), right panel), suggesting
possible leakiness of the 𝛼MyHC promoter. At day 1 from
the infection, a small population of skin and cardiac canine
fibroblasts died; however, they maintained a comparable
proliferation rate to GHMT Bj-1 fibroblasts in the following
days (Figure 2(e)). With the prospective of a possible cell
therapy and functional tests after cell conversion, we trans-
duced GHMT CFs and GHMT SFs with lentiviral vectors
carrying microdystrophin (𝜇dys) gene, and 𝜇dys expression
was evaluated via qRT-PCR in transduced cells (Figure 2(f)).
As shown in Figure 2(g), infected cells maintained a high and
comparable expression of GHMT transcription factors over
the 28 days of differentiation.
3.3. Evaluation of the Conversion of Fibroblast to ciCLMs. To
evaluate the conversion of fibroblasts into cardiac myocyte-
like cells, we analysed the expression of early (MEF2c,
NKX2.5, GATA4, TBX5, and HAND2) and late (CNX43,
TNNT2, ACTC1, and MYH6) cardiac markers at differ-
ent time points (Figure 3). After 14 days in differentiation
medium, we detected an increase of the expression of late
cardiac markers. On the contrary, we did not detect a consis-
tent fold change in the expression of endogenous early cardiac
markers. It is likely that due to the constitutive expression
of the exogenous transcription factors genes involved in the
first steps of cardiomyogenesis were repressed. Interestingly
we found that CNX43, TNT and ACTC1 were significantly
more highly expressed in GHMT CFs compared to GHMT
SFs and Bj-1, suggesting that fibroblasts derived from a
cardiac niche could retain a higher conversion potential to
cardiac myocytes-like cells. Moreover, confirmatory results
were obtained with FACS (Figure 4(a)) and Western blot
analysis (Figure 4(b)).When cells were stained for the cardiac
marker Tnnt2 and evaluated via FACS analysis (Figure 4(a)),
we detected 17.3% and 12% Tnnt2+ cells, respectively, in
GHMT CFs and GHMT SFs. In addition, Western blot
analysis with anti-TnnI3 antibodies revealed a higher amount
of troponin I protein inGHMTCFs compared to GHMTSFs.
On the contrary, troponin I was not detected in the negative
control (Figure 4(b)). Consistent with the upregulation of
cardiac specific genes during the conversion, we found an
important decrease in the expression level of the fibroblast
markers HSP47 (Figure 4(c)) and CD90 (Figure 4(d)) in
GHMTCFs and GHMT SFs compared to controls. Although
between 20 and 30% of cells still expressed Thy1 (CD90), we
cannot exclude that the reprogramming protocol altered their
fibroblast phenotype. Up to 95%of converted cardiomyocytes
survive and we managed to keep them in culture for 30
days. Immunofluorescence analysis was then performed (at
day 14) to further elucidate the protein organization in
the ciCLMs. GHMT CF, GHMT SF, and Bj-1 cells stained
positive for alpha sarcomeric actinin (𝛼SA), connexin 43
(CNX43),myosin heavy chain (MyHC), and cardiac troponin
T (TNNT2) (Figures 5(a) and 5(b)).The results obtained from
immunofluorescence analysis seem to represent a spectrum
of cardiac reprogramming, where ciCLMs induced from
adult cardiac and skin fibroblasts are composed of different
cell types, previously referred to as types A, B, and C [10].
However, we could not observemore organized sarcomeres in
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Figure 2: Viral transduction and exogenous gene expressions. (a) Schematic representation of the lentiviral vectors carrying the human
sequence of the transcription factor genes (GATA4-MEF2C-TBX5-HAND2), the microdystrophin gene, and the GFP reporter gene. (b) The
GFP reporter gene under the control of the 𝛼-MyHC promoter was already expressed 48 hours after transduction. (c) Fibroblasts underwent
morphology changes 7 days after transduction and become flattened and binucleated cells expressing GFP. (d) Immunofluorescence analysis
on GHMT CF alone (top left panel) and in coculture with neonatal rat cardiomyocytes (bottom left panel), with antibodies against GFP
(green) and myosin heavy chain (red), shows double positive cells and single positive cells for GFP (right panel). (e) Cell growth curve
after transduction shows a decrease of cell proliferation (𝑛 = 5/cell type). (f) Fold induction of microdystrophin (𝜇dys) mRNA expression
in transduced cells compared to the control; 𝑛 = 5 ∗𝑝 < 0.01, CF and SF versus controls (CF and SF transduced with empty vector). (g)
Exogenous transcription factors expression (𝑛 = 5) after transduction shows high induction levels during the 28 days of differentiation.
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Figure 3: Characterization of GHMT transduced cells. qRT-PCR was performed at day 7 and at day 14 from transduction. Early endogenous
cardiac marker genes (Nkx2.5, Gata4, and Mef2c-Tbx5-hand2) and late cardiac marker genes (CNX43, TNNT2- ACTC1 and MYH6) were
analysed. Fold induction of mRNA expression in transduced cells compared to the controls (cells transduced only with 𝛼-MHC-GFP vector).
The expression of late cardiac markers identified canine-induced cardiac-like myocytes (ciCLMs) in the transduced cell populations; 𝑛 = 5,
2-way ANOVA test, ∗𝑝 < 0.01.
ciCLMs at day 30 compared to day 14 and indeed no beating
cells were detected.
3.4. Xenotransplantation of ciCLMs in SCID/Beige Mice. In
order to evaluate the ability to contribute to the heart devel-
opment, we set up a xenotransplant model of the GHMT
cells into developing heart of 1-day-old SCID/Beige pups, as
previously reported [32]. GFPpositive cells were sorted after 7
days from GHMT transduction (Figure 6(a)) and 50.000
cells of each cell type were injected directly in the heart of
12 pups. Three weeks after the injection, mice were sacrificed
and hearts were explanted and immunostained for GFP
and dystrophin. Immunofluorescence analysis revealed that
ciCLMs were able to engraft in the growing heart as shown
in Figure 6(b). Interestingly, we found that ciCLMs generated
fromCFhave a higher engraftment capacity (Figures 6(c) and
6(d), left panel) compared to those generated from SF. On
the contrary, injected GFP positive CF cells, used as negative
control, were confined in the interstitial area (Figure 6(d),
right panel).
4. Discussion
Duchenne and Becker muscular dystrophies are a group
of inherited diseases that affect both skeletal and cardiac
muscles. In particular, adolescence patients tend to develop
dilated cardiomyopathy that could result in arrhythmia,
fatigue, shortness of breath, and swelling of the legs and feet,
and that could lead to heart failure and sudden death [33].
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Figure 4: Expression of cardiac and fibroblast markers in ciCLMs. (a) Examples of intracellular FACS analysis for the isolation of Tnnt2+ cells
(green) and isotype controls (red) in ciCLMs after 14 days of differentiation. (b) Example ofWestern blot analysis after 14 days of differentiation
showed the presence of cardiac troponin I as a late cardiac marker protein in ciCLMs derived from both GHMT CF and GHMT SF cells.
Densitometry quantification performed with ImageJ software showed that Tnni3 was 3,2-fold more expressed in GHMT CF compared to
GTMH SF. Troponin I was absent in CF and SF transduced with 𝛼-MHC-GFP vector. (c) Expression of the fibroblast marker HSP47, in
transduced cells compared to control cells (transduced with only 𝛼-MHC-GFP vector). HSP47 expression strongly decreases in ciCLMs after
7 and 14 days of differentiation compared to the controls; 𝑛 = 5, 2-way ANOVA test, ∗𝑝 < 0.01. (d) Examples of FACS analysis on ciCLMs
confirmed a reduced number of Thy1 (CD90) + cells after 7 days of differentiation.
Cardiac fibroblasts (CFs) are involved in the healing and
remodeling process of the heart resulting in scar tissue for-
mation with limited contractile properties. A possible ther-
apeutic approach would be to convert CFs into functional
cardiac myocytes. Indeed several studies showed the pos-
sibility to generate cardiomyocytes by direct reprograming
with specific transcription factors [10–14]. In this context,
we isolated cardiac and skin fibroblasts from GRMD dogs,
a large animal model for Duchenne muscular dystrophy, and
attempted to reprogram them into canine-induced cardiac-
like myocytes (ciCLMs) using a conversion protocol recently
described [6, 14]. Our results showed that the overexpression
of four cardiac transcription factors (GHMT) is sufficient to
convert cardiac and skin canine fibroblasts into ciCLMs. In
order to generate a reliable protocol, we employed cell-sorting
technology to obtain CD90+ cells as a starting cell population
from fresh isolated cells. This cell population was up to 100%
positive for Vimentin and HSP47. As already described in
literature [34], the healthiness and freshness of the starting
population represent a critical step for obtaining good rate
and quality of conversion to ciCLMs. After isolation, cells
were highly proliferative as demonstrated by cell growth
curves and the Ki67 staining. However, after some passages
in culture, some signs of senescence were observed. To
preserve proliferative potential, cells were expanded for 10
days after isolation and then frozen for later reprogramming
experiments. In our study, we included Bj-1 fibroblast cells as
controls and they showed comparable conversion efficiency
with canine fibroblasts. Nevertheless, the use of human tran-
scription factors could represent a further limitation in our
reprogramming method. GFP+ cells were already detectable
48 hours after transduction with GHMT and 𝛼MHC-GFP
and at 14 days cells become flattened and binucleated,
expressing late cardiac markers such as CNX43, TNNT2,
ACTC1 and MYH6. Early endogenous cardiac genes did not
show evident modulation during the reprograming protocol,
highlighting the fact that cardiac differentiation occurred
differently from cardiac embryonic development. In all our
attempts, no beating cells were detected from cells subjected
to the direct conversion protocol as previously reported
for human fibroblasts [35]. We speculate that this could be
due to two different issues in our direct reprogramming
protocol. First, we used human transcription factor cDNA,
although the human transcription factor sequences used for
transduction are well conserved among mammalian species
and the similarity between canine and human sequences is
between 96% and 98%. Second it is well recognized that
isolated cells from newborn pups retain a higher plastic-
ity and regeneration potential compared with cell derived
from adult animals. However, in our experiments we used
fibroblasts isolated from skin and heart biopsies of adult
deceased GRMD dogs, since we could not obtain cardiac
fibroblasts from pups due to ethical restrictions for large
animal models. We speculate that those limitations could
have affected the efficiency of our reprogramming protocol.
Another important issue emerging in the recent literature is
the stoichiometric ratio of reprogramming factors.
Indeed, using a mixture of viruses expressing individ-
ual factors has heterogeneous and unmanageable ratio of
reprogramming factor expression among infected fibroblasts,
which results in variable and low reprogramming effective-
ness.
To further investigate the conversion potential efficiency
of canine fibroblasts subjected to reprogramming, we anal-
ysed the expression of late cardiac markers by qPCR, the
percentage of Tnnt2+ cells via FACS, and quantified Tnni3
protein via Western blot. Interestingly our results showed
for the first time that GRMD canine cardiac fibroblasts
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Figure 5: Localization of cardiac markers in ciCLMs. (a) Alpha sarcomeric actinin (red) and connexin 43 (green) were present in ciCLMs in
similar amount to reprogrammed Bj-cells. (b) Immunofluorescence analysis revealed the expression of alpha sarcomeric actinin (𝛼SA, red),
connexin 43 (CNX43, green; white arrows indicate CNX43 expression on the cell membrane), myosin heavy chain (MyHC, red), and cardiac
troponin T (red) in ciCLMs after 14 days under differentiating conditions. (c) ciCLM cells did not express cardiac markers homogenously. A
few cells expressing 𝛼SA were GFP negative and vice versa (left panels) and occasionally CNX43 (green arrows) and 𝛼SA (red arrows) were
mutually exclusively expressed (right panel).
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Figure 6: ciCLMs in vivo injection. (a) Immunofluorescence analysis for GFP expression ciCLMs after cell sorting for GFP and before
injections. (b) 2 × 105 GFP positive cells were injected directly in the heart of 2-day-old pups. After 14 days pups were sacrificed and heart
sections were prepared and double stained with antibodies against dystrophin (red) and GFP (green). (c) Average number of ciCLMs GFP
positive cells per section; 𝑛 = 3. (d) Double staining with antibodies against myosin heavy chain (red) and GFP (green).
have higher conversion ability to ciCLM cells compared to
skin and dermal human fibroblasts. Indeed, qPCR analysis
showed that GHMT CFs expressed higher level of CNX43,
TNNT2 and ACTC1 after 14 days of cardiac differentiation.
In addition, 17.3% of GHMTCFs and 12% of GHMT SFs were
positive for Tnnt2. Densitometry quantification showed that
Tnni3 was 3,2-fold more expressed in GHMT CF compared
to GTMH SF. Furthermore, both GHMT CF and GTMH
SF downregulated the fibroblast markers, HSP47 and CD90,
after 14 days of conversion. Consistent with literature, IF
analysis revealed that ciCLM cells do not express all the
cardiac markers homogenously, since they could represent a
spectrum of cardiac differentiation [10].
Finally, sorted GFP+ ciCLM cells at day 7 of conversion,
injected into the heart of SCID/Beige newborn pups, were
able to engraft the developing heart and expressed dystrophin
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and MyhC. On the contrary, injected GFP-CFs remain
confined in the interstitial area. Although the mechanisms
and stoichiometric effects in cell fate specification are still
largely unknown, this latter result highlights that GHMT
forced expression is sufficient to generate cardiac progenitors
from somatic adult canine cells able to integrate into the
cardiac niche.
5. Conclusions
In this studywe provided evidences that canine fibroblasts are
converted to immature cardiac myocytes (ciCLMs) with the
GHMT reprogramming protocol. We showed that ciCLMs
express cardiac late markers and ability to engraft in a
developing heart in xenotransplantation experiment. More-
over, we found that fibroblasts isolated from cardiac tissue
are more prone to cardiac conversion than skin fibroblasts,
suggesting that an epigenetic regulation shapes cardiac cell
fate. Polycistronic constructs to express homogenously each
factor as recently reported for human fibroblasts [36] could
improve this methodology to obtain a large number of canine
ciCLMs.
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